Integrated medical device innovation | Domestic tumor minimally invasive technology

Medical Network October 9th China's micro-invasive technology research and development and application expert seminar was held in Beijing recently. Fan Xiaodong, vice president of China Medical Device Industry Association, Meng Xianli, editor-in-chief of Health Times, Zhao Ping, chairman of China Cancer Foundation, and many others Well-known oncology surgeons from the top three hospitals in China attended the seminar to discuss the scientific and technological innovation model in the field of minimally invasive tumors in China.

In the past 40 years of reform and opening up, the state has continuously increased medical instruments Policy support, policy intensive, domestic medical equipment ushered in unprecedented new development opportunities.

In this regard, Fan Xiaodong, vice president of China Medical Device Industry Association, proposed that the State Intellectual Property Office issued a clear text on the top ten industries supported by the state in 2018, among which health Among the branches of the industry, a total of six categories of medical devices will be supported by a large number of high-end medical devices.

Experts attending the meeting said that the domestic medical device industry has entered a second period of rapid development. In the critical period of national economic transformation, the medical device industry will be the key area of ​​the real economy, with key support. Under policy support, technology, high-end Domestic medical equipment import substitution will press the shortcut key, cost-effective Chinese manufacturing will launch a more powerful challenge for international brands on a global scale.

With the advent of the era of precision medicine, Tumor Treatment is more minimally invasive, efficient and individualized, and gradually becomes the mainstream of cancer treatment.

Minimally invasive treatment from the past single blood vessel embolization treatment of liver cancer to the current interventional embolization for lung cancer, ovarian cancer, kidney cancer, etc., from ultrasound-guided percutaneous puncture to CT, MRI-guided puncture diagnosis and puncture treatment of whole body tissues and organs, micro Invasive treatment has penetrated into the whole body tissues and organs, the treatment of different tumors. More and more cancer patients benefit from it and bring development benefits to the development of tumor minimally invasive devices.

In this regard, the participating experts believe that clinicians should also participate in the design of surgical instruments. In the history of surgical development in the past century, many foreign experts are directly involved in the innovation of surgical instruments. In the past 20 years, the country has also realized Let clinicians participate in the need for device creation.

Experts attending the meeting suggested that minimally invasive surgery has gone on for 20 or 30 years. Many traditional surgical instruments should be innovated within the framework of minimally invasive surgery. But this innovation must not be limited to clinical, but rather The outbreak of the discipline after the joint force.

Some innovative wisdom from the clinical line of sublimation, medical equipment enterprise As a bridge, through the interdisciplinary combination of materials, machinery, electronics, software, or in the field of sound and optoelectronics, and ultimately to produce a complete technical solution, will the innovation in the field of high-end medical devices, is the future domestic tumor innovation The key to technology.

The issue of intellectual property protection has also been frequently mentioned in this seminar. Among them, there are many governments that attach great importance to supporting independent innovation and intellectual property internationalization policies, and with the rapid development of technology, the medical device field continues to integrate and In the process of innovation, on the one hand, there are a lot of simple reproductions of imitation infringement in the industry, on the other hand, it needs to face global competition and disputes.

Domestic medical device enterprises must go global and move toward high-end development. They must not only focus on R&D and technological innovation, but also need to improve the level of intellectual property declaration and protection, and actively carry out the globalization of intellectual property.

In this regard, Nie Honglin, founder and chief scientist of Shanghai Yisi Medical Technology Co., Ltd., said that Yisi Medical has tried to incorporate innovative clinical surgeons, scientists from relevant research institutes, and engineering experts into the R&D team. Fully understand the needs of experts in the clinical frontline for medical equipment, summarize and refine the innovative ideas and directions.

According to Nie Honglin, after the international medical giant has collected the valuable innovation wisdom of medical experts, the only way to pay for a cheap technical consulting fee is that Yisi Medical has jointly filed patents with experts after successful product development. The doctor is the first of all inventors. After the company has the corresponding economic benefits, let the experts participate in the distribution of profits.

It is reported that through cooperation like this think tank model, Yisi Medical Start a business Up to now, a large number of technological innovations have been carried out, and invention patents have been actively applied, and the global intellectual property strategic layout has been implemented. Phased results have been achieved. At present, Yisi Medical has applied for 87 patents and applied for 42 trademarks.